The Effect of a Four-Month Low-Carbohydrate Diet on Visceral Adipose Tissue in Obese Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Background: Previous studies have shown a relationship between Visceral Adipose Tissue (VAT) and Hepatic Fat Content (HFC), and increases in HFC are linked to metabolic abnormalities similar to those associated with elevated VAT. Several short-term and long-term studies have supported these findings...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrients Vol. 17; no. 17; pp. 2905 - 2920
Autores principales: Rotolo, Ornella, Bonfiglio, Caterina, Reddavide, Rosa, Cisternino, Anna Maria, Inguaggiato, Rosa, Giannelli, Gianluigi
Formato: research tables/charts Journal Article
Publicado: MDPI Sep2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=187981306&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 187981306
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726643
        B0TT
      jtl: Nutrients
      issn: 20726643
      maglogo: N
    pubinfo:
      dt: Sep2025
      vid: 17
      iid: 17
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        187981306
        187981306
        187981306
        10.3390/nu17172905
        187981306
      ppf: 2905
      ppct: 15
      formats:
      tig:
        atl: The Effect of a Four-Month Low-Carbohydrate Diet on Visceral Adipose Tissue in Obese Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
      aug:
        au:
          Rotolo, Ornella
          Bonfiglio, Caterina
          Reddavide, Rosa
          Cisternino, Anna Maria
          Inguaggiato, Rosa
          Giannelli, Gianluigi
        affil: Clinical Trial Unit, National Institute of Gastroenterology IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy
      sug:
        subj:
          Diet, Low Carbohydrate
          Abdominal Fat Metabolism
          Metabolic Diseases Complications
          Nonalcoholic Fatty Liver Disease
          Obesity
          Human
          Funding Source
          Descriptive Statistics
          Confidence Intervals
          Male
          Female
          Adult
          Middle Age
          Aged
          Data Analysis Software
          Retrospective Design
          Record Review
          Power Analysis
          Wilcoxon Rank Sum Test
          Anthropometry
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Background: Previous studies have shown a relationship between Visceral Adipose Tissue (VAT) and Hepatic Fat Content (HFC), and increases in HFC are linked to metabolic abnormalities similar to those associated with elevated VAT. Several short-term and long-term studies have supported these findings. Lifestyle interventions remain the cornerstone of treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), although the ideal dietary regimen is still under debate. Methods: Data on 2040 patients were extracted from the Clinical Nutrition Unit database between 2017 and 2019. Of these, 474 subjects with MASLD and Body Mass Index (BMI) ≥ 35 kg/m2 were treated with a four-month low-carbohydrate dietary intervention called the "Strong Diet" (StD). VAT and liver stiffness were measured at baseline and after four months of treatment using ultrasound. Results: Our study demonstrates the significant efficacy of StD in reducing VAT in MASLD patients with moderate hepatic steatosis. In subjects with severe steatosis, there is no statistically significant response to dietary intervention. This may be attributed to several irreversible molecular mechanisms that fundamentally alter the hepatic microenvironment and limit the liver's capacity for regeneration and metabolic recovery. Conclusions: Improvements were largely confined to patients with moderate MASLD, with limited benefit in severe disease. Although dietary intervention remains the cornerstone of MASLD management, patients with severe steatosis should be informed about the potential limited resolution of steatosis, even with optimal metabolic control.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N